Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.India-based pharmaceutical company Dr Reddy's Laboratories has launched the authorized generic version of GlaxoSmithKline's Imitrex tablets 25mg, 50mg, and 100mg in the US.
Subscribe to our email newsletter
Dr Reddy’s is said to be the first company to launch an authorized generic version of Imitrex tablets in the US market. GlaxoSmithKline Imitrex tablets are indicated for the acute treatment of migraine attacks in adults.
Dr Reddy’s has previously announced that it had settled patent litigation with GlaxoSmithKline relating to sumatriptan succinate tablets, the generic version of GlaxoSmithKline Imitrex tablets. The specific financial terms and conditions of the settlement have not been disclosed.